PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50121C00084 — PRALIDOXIME CHLORIDE PROTOPAM

PRALIDOXIME CHLORIDE PROTOPAM is a federal NONE award for Department of Health and Human Services (HHS) held by BAXTER HEALTHCARE CORPORATION. Estimated value $39.2M ($39.2M obligated). Current period of performance ends Sep 29, 2026. Last award drew 3 bidders.

$39.2M
Estimated Value
Sep 29, 2026
PoP End / Expires
3
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

BAXTER HEALTHCARE CORPORATION holds $25.7M across 942 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 3 offers. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75A50121C00084
AgencyDepartment of Health and Human Services (HHS)
IncumbentBAXTER HEALTHCARE CORPORATION
UEIRSKLEFCZ6127
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC3650
PoP end (current)Sep 29, 2026
Obligated$39.2M

Recompete timing

Public
Expiring in 44 days

Current PoP ends Sep 29, 2026 (44 days remaining). Agencies typically plan 12–18 months ahead — at 1.4 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

BAXTER HEALTHCARE CORPORATION$25.7M obligated across 942 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($25.7M) · all agencies
Department of Health and Human Services (HHS)$16.3M · 63%Department of Veterans Affairs (VA)$6.0M · 23%Department of Defense (DOD)$3.0M · 12%Department of Justice (DOJ)$336K · 1%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75A50121C00084
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open BAXTER HEALTHCARE CORPORATION’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50121C00084?

75A50121C00084 (PRALIDOXIME CHLORIDE PROTOPAM) is a Department of Health and Human Services (HHS) award with an estimated value of $39.2M, currently held by BAXTER HEALTHCARE CORPORATION. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50121C00084?

BAXTER HEALTHCARE CORPORATION is the incumbent with $25.7M across 942 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does 75A50121C00084 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50121C00084